01Definition
Averaging changes your entry cost and total exposure. Its rationale depends on evidence and limits, not direction alone.
02Why it matters
A cheaper price can accompany a weaker thesis; a higher price can accompany better information.
03What to check
- What improved independently of price
- Whether the original invalidation still holds
- New total exposure, exit depth, and risk budget
04Healthy / Dangerous
Healthy
The add survives a fresh review of evidence and cost.
Dangerous
A falling price becomes the entire reason to buy more.
05Beginner mistake
Improving the average while worsening portfolio risk.
06Takeaway
Cheaper is not evidence.
See the idea
- 01
Price falls below the first entry.
- 02
The trader wants to add, but buyers and liquidity are weakening.
- 03
A lower average does not repair the deteriorating case.
Try it on a token
See it in Meme Fast → SwingReview observed structure and reported liquidity, then check sampled flow in Inspect. These do not determine your add size or execution price.
Go deeper
Neither averaging up nor averaging down is automatically justified. Review location, thesis, current hygiene, invalidation, and fresh risk together. A technically attractive area can still fail; a stronger thesis can still be too expensive or too illiquid for the intended order.
Need the basics? Revisit 101A →